References

  1. Ali SA, Mavundla TR, Fantu R, Awoke T. Outcomes of TB treatment in HIV co-infected TB patients in Ethiopia: a cross-sectional analytic study. BMC Infectious Diseases. 2016; 16(1): 640. PubMed | Google Scholar

  2. Raviglione M, Sulis G. Tuberculosis 2015: burden, challenges and strategy for control and elimination. Infectious Disease Reports. 2016; 8(2): 6570. PubMed | Google Scholar

  3. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary medicine. 2013; 2013: 828939. PubMed | Google Scholar

  4. Esmail H, Barry CE, Young DB, Wilkinson RJ. Philosophical Transactions of the Royal Society B: Biological Sciences. The ongoing challenge of latent tuberculosis. 2014; 369(1645): 20130437. PubMed | Google Scholar

  5. World Health Organization. Global tuberculosis report 2013. Geneva. 2013. Google Scholar

  6. Qian H, Li Y, Nielsen PV, Hyldgård CE, Wong TW, Chwang ATY. Dispersion of exhaled droplet nuclei in a two-bed hospital ward with three different ventilation systems. Indoor air. 2006; 16(2): 111-128. PubMed | Google Scholar

  7. Tschopp R, Schelling E, Hattendorf J, Aseffa A, Zinsstag J. Risk factors of bovine tuberculosis in cattle in rural livestock production systems of Ethiopia. Preventive veterinary medicine.2009; 89(3-4): 205-211. PubMed | Google Scholar

  8. Centers for Disease Control and Prevention. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force. Centers for Disease Control and Prevention. 2009; 58(3): 1-43. PubMed | Google Scholar

  9. Sulis G, Centis R, Sotgiu G, D'Ambrosio L, Pontali E, Spanevello A et al. Recent developments in the diagnosis and management of tuberculosis. NPJ Primary Care Respiratory Medicine. 2016; 26: 16078. PubMed | Google Scholar

  10. Sia IG, Wieland ML. Current concepts in the management of tuberculosis. Elsevier. 2011; 86(4): 348-361. PubMed | Google Scholar

  11. Rao J. QRS for BDS II Year. Elsevier Health Sciences. 2014. Google Scholar

  12. Jordan TS, Davies PD. Clinical tuberculosis and treatment outcomes. The International Journal of Tuberculosis and Lung Disease. 2010; 14(6): 683-688. PubMed | Google Scholar

  13. Vesosky B, Turner J. The influence of age on immunity to infection with Mycobacterium tuberculosis. Immunological reviews. 2005; 205: 229-243. PubMed | Google Scholar

  14. Mehta JB, Emery MW, Girish M, Ryland Jr P, Roy TM. Atypical Pott's disease: localized infection of the thoracic spine due to Mycobacterium avium-intracellulare in a patient without human immunodeficiency virus infection. Southern medical journal. 2003; 96(7): 685-689. PubMed | Google Scholar

  15. World Health Organization. Global tuberculosis control: WHO report 2011. Geneva. 2011. Google Scholar

  16. World Health Organization. Global tuberculosis report 2014. Geneva. 2014. Google Scholar

  17. World Health Organization. Global tuberculosis report. 2016. Google Scholar

  18. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. The lancet. 2013; 380(9859): 2197-2223. PubMed | Google Scholar

  19. World Health Organization. Global Tuberculosis Report 2015. Geneva: world Health Organization. 2015. Google Scholar

  20. Dalbo M, Tamiso A. Incidence and Predictors of Tuberculosis among HIV/AIDS Infected Patients: a five-year retrospective follow-up study. Advances in Infectious Diseases. 2016; 6(02): 70-81. Google Scholar

  21. Galan A, Cucu A. Disability-adjusted life years as a key tool for the analysis of the burden of disease. Health: Systems-Lifestyle-Policies. 2013; 142. Google Scholar

  22. Ukwaja KN, Modebe O, Igwenyi C, Alobu I. The economic burden of tuberculosis care for patients and households in Africa: a systematic review. The International Journal of Tuberculosis and Lung Disease. 2012; 16(6); 733-739. PubMed | Google Scholar

  23. Yarnell J, Mendis S, Connolly S, Sambo LG, Kebede D, Jakab Z et al. Epidemiology and Disease Prevention: a global approach. Global health in the 21st century. 2013; 369. Google Scholar

  24. World Bank. World Development Indicators. 2014. Google Scholar

  25. World Health Organization. Global tuberculosis report 2016. Google Scholar

  26. Inambao A, Adan A, Mohamed A. Report on the evaluation of the global fund TB program in Somalia. 2013. Google Scholar

  27. Sindani I. Multidrug-Resistant Tuberculosis, Somalia, 2010-2011. Emerging Infectious Disease journal-CDC. 2013; 19(3): 478-480. PubMed | Google Scholar

  28. Korenromp EL, Williams BG, Gouws E, Dye C, Snow RW. Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. The Lancet infectious diseases.2003; 3(6): 349-358. PubMed | Google Scholar

  29. Zager EM, McNerney R. Multidrug-resistant tuberculosis. BMC Infectious Diseases.2008; 8: 10. PubMed | Google Scholar

  30. Barlett JE, Kotrlik JW, Higgins CC. Organizational research: determining appropriate sample size in survey research. Information technology, learning and performance journal. 2001; 19(1): 43-50. Google Scholar

  31. Gebrezgabiher G, Romha G, Ejeta E, Asebe G, Zemene E, Ameni G. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: a five-Year retrospective study. PloS one. 2016; 11(2): e0150560. PubMed | Google Scholar

  32. Berhe G, Enquselassie F, Aseffa A. Treatment outcome of smear-positive pulmonary tuberculosis patients in Tigray Region, Northern Ethiopia. BMC public health. 2012; 12: 537. PubMed | Google Scholar

  33. Lange C, Abubakar I, Alffenaar JWC, Bothamley G, Caminero JA, Carvalho ACC et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. European Respiratory Journal. 2014 July; 44(1): 23-63. PubMed | Google Scholar

  34. Vasankari T, Holmström P, Ollgren J, Liippo K, Kokki M, Ruutu P. Risk factors for poor tuberculosis treatment outcome in Finland: a cohort study. BMC public health. 2007; 7: 291. PubMed | Google Scholar

  35. Seddon JA, Hesseling AC, Willemse M, Donald PR, Schaaf HS. Culture-confirmed multidrug-resistant tuberculosis in children: clinical features, treatment and outcome. Clinical infectious diseases. 2012; 54(2): 157-166. PubMed | Google Scholar

  36. Babatunde OA, Elegbede OE, Ayodele M, Fadare JO, Isinjaye AO, Ibirongbe DO et al. Factors affecting treatment outcomes of tuberculosis in a tertiary health center in Southwestern Nigeria. Int Rev Soc Sci Hum. 2013; 4(2): 209-218 . Google Scholar

  37. Sengul A, Akturk UA, Aydemir Y, Kaya N, Kocak ND, Tasolar FT. Factors affecting successful treatment outcomes in pulmonary tuberculosis: a single-center experience in Turkey, 2005-2011. he Journal of Infection in Developing Countries. 2015; 9(08): 821-828. PubMed | Google Scholar

  38. Olukolade R, Hassan A, Ogbuji Q, Olujimi S, Okwuonye L, Kusimo O et al. Role of treatment supporters beyond monitoring daily drug intake for TB-patients: findings from a qualitative study in Nigeria. Journal of Public Health. 2017 April; 9(4): 65-73. Google Scholar

  39. Muture BN, Keraka MN, Kimuu, KP, Kabiru EW, Ombeka VO et al. Factors associated with default from treatment among tuberculosis patients in nairobi province, Kenya: a case control study. BMC Public Health. 2011; 11: 696. PubMed | Google Scholar

  40. Havlir DV, Getahun H, Sanne I, Nunn P. Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. Jama.2008; 300(4): 423-430. PubMed | Google Scholar

  41. Widjanarko B, Gompelman M, Dijkers M, Van der Werf MJ. Factors that influence treatment adherence of tuberculosis patients living in Java, Indonesia. Patient Prefer Adherence. 2009; 3: 231-238. PubMed | Google Scholar

  42. Liang L, Wu Q, Gao L, Hao Y, Liu C, Xie Y et al. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China. horax. 2012; 67(7): 632-638. PubMed | Google Scholar

  43. Mesfin MM, Newell JN, Madeley RJ, Mirzoev TN, Tareke IG, Kifle YT et al. Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia. BMC Public Health. 2010; 10: 173. PubMed | Google Scholar

  44. Chimbindi N, Bärnighausen T, Newell ML. Patient satisfaction with HIV and TB treatment in a public programme in rural KwaZulu-Natal: evidence from patient-exit interviews. BMC health services research. 2014 January; 14: 32. PubMed | Google Scholar

  45. Karyadi E, West CE, Schultink W, Nelwan RH, Gross R, Amin Z et al. A double-blind, placebo-controlled study of vitamin A and zinc supplementation in persons with tuberculosis in Indonesia: effects on clinica lresponse and nutritional status. The American journal of clinical nutrition. 2002; 75(4): 720-727. PubMed | Google Scholar

  46. World Health Organization. The Stop TB Strategy: building on and enhancing DOTS to meet the TB-related Millennium Development Goals. 2006. Google Scholar

 

 

 

 

 

 

 

 <